Josh Tarnoff
Company: NephCure Kidney International
Job title: Chief Executive Officer
Seminars:
Panel & Audience Discussion: Enhancing Diversity in CKD Clinical Trials: What is Needed, What is Working, & What is Next? 11:30 am
Explore initiatives that have increased participation of underrepresented groups in CKD clinical trials where these efforts have yielded more inclusive trial populations Discuss the importance of diverse representation in trials for generating more accurate and generalizable data ensuring that treatments are effective across all demographics Explore new and emerging methods for ensuring diverse trial participation,…Read more
day: Day Two Track 2
Breakfast Briefing – Understanding Physicians & Primary Care Givers Perspectives 7:40 am
The Breakfast Briefings at the CKD summit is designed to foster open and insightful conversations in an intimate setting, providing a unique opportunity for attendees to interact with top physicians, researchers, primary care givers and patient advocates. In these roundtable discussions, experts will share their personal experiences, insights, and practical knowledge on key challenges and…Read more
day: Day Two AM
Revolutionizing FSGS: Addressing Proteinuria & GFR as Clinical Endpoints in FSGS Through the PARASOL Initiative 11:30 am
Explore the current challenges in identifying reliable, meaningful endpoints in FSGS clinical trials, and how the PARASOL initiative seeks to establish the relationship between short-term biomarker changes (proteinuria and GFR) and long-term outcomes Exploring how global patient registries and real-world data from diverse cohorts are informing endpoint identification, particularly in rare diseases like FSGS where…Read more
day: Pre-Conference Focus Day